{"id":2303,"date":"2021-02-22T13:53:51","date_gmt":"2021-02-22T04:53:51","guid":{"rendered":"https:\/\/fukurou-hifuka.com\/blog\/?post_type=media_info&#038;p=2303"},"modified":"2021-02-22T13:53:53","modified_gmt":"2021-02-22T04:53:53","slug":"the-journal-of-dermatology%e3%80%80%ef%bd%9e%e5%a4%9a%e6%b1%97%e7%97%87%e6%96%b0%e8%a6%8f%e5%a4%96%e7%94%a8%e8%96%ac%e3%81%ae%e8%ab%96%e6%96%87%ef%bd%9e","status":"publish","type":"media_info","link":"https:\/\/fukurou-hifuka.com\/blog\/media_info\/the-journal-of-dermatology%e3%80%80%ef%bd%9e%e5%a4%9a%e6%b1%97%e7%97%87%e6%96%b0%e8%a6%8f%e5%a4%96%e7%94%a8%e8%96%ac%e3%81%ae%e8%ab%96%e6%96%87%ef%bd%9e\/","title":{"rendered":"The Journal of Dermatology\u3000\uff5e\u591a\u6c57\u75c7\u65b0\u898f\u5916\u7528\u85ac\u306e\u8ad6\u6587\uff5e"},"content":{"rendered":"\n<p>Yokozeki H,Fujimoto T, et.al.<br>A Phase 3, multi-center, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis<br>http:\/\/dx.doi.org\/10.1111\/1346-8138.15668<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","class_list":["post-2303","media_info","type-media_info","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/fukurou-hifuka.com\/blog\/wp-json\/wp\/v2\/media_info\/2303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fukurou-hifuka.com\/blog\/wp-json\/wp\/v2\/media_info"}],"about":[{"href":"https:\/\/fukurou-hifuka.com\/blog\/wp-json\/wp\/v2\/types\/media_info"}],"wp:attachment":[{"href":"https:\/\/fukurou-hifuka.com\/blog\/wp-json\/wp\/v2\/media?parent=2303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}